Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,868,500 | 1,456,500 | 8,318,400 | 6,822,700 | 5,568,800 |
| Depreciation Amortization | 598,000 | 273,600 | 1,232,600 | 891,900 | 603,900 |
| Income taxes - deferred | -93,500 | 11,200 | 62,400 | -23,400 | -11,300 |
| Accounts receivable | N/A | N/A | -127,200 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | -477,700 | N/A | N/A |
| Other Working Capital | -172,900 | -1,408,100 | -1,687,200 | -1,763,700 | -1,307,800 |
| Other Operating Activity | -322,300 | 49,200 | -2,484,700 | -3,054,600 | -3,490,800 |
| Operating Cash Flow | $2,877,800 | $382,400 | $4,836,600 | $2,872,900 | $1,362,800 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 111,200 | 36,800 | 93,900 | 82,200 | 55,300 |
| PPE Investments | -540,100 | -258,300 | -1,033,900 | -707,400 | -444,000 |
| Net Acquisitions | -849,300 | -849,300 | -6,562,900 | N/A | -6,917,700 |
| Purchase Of Investment | -154,800 | -83,000 | -247,500 | -196,700 | -146,600 |
| Sale Of Investment | 412,000 | 54,500 | 609,800 | 498,400 | 416,400 |
| Other Investing Activity | -250,300 | 38,400 | -942,300 | -7,718,000 | -581,100 |
| Investing Cash Flow | $-1,271,300 | $-1,060,900 | $-8,082,900 | $-8,041,500 | $-7,617,700 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -235,400 | 1,748,700 | 995,400 | 1,058,900 | 1,564,300 |
| Debt Issued | 988,600 | -276,300 | 6,556,400 | 4,448,300 | 4,448,300 |
| Debt Repayment | -276,300 | N/A | -2,866,400 | -600,300 | -600,200 |
| Common Stock Repurchased | -500,000 | -500,000 | -4,400,000 | -4,100,000 | -3,500,000 |
| Dividend Paid | -1,345,500 | -671,300 | -2,409,800 | -1,822,600 | -1,235,200 |
| Other Financing Activity | -197,900 | -194,400 | -200,100 | -195,200 | -195,200 |
| Financing Cash Flow | $-1,566,500 | $106,700 | $-2,324,500 | $-1,210,900 | $482,000 |
| Exchange Rate Effect | -12,400 | -66,700 | -89,900 | -54,900 | 64,900 |
| Beginning Cash Position | 2,337,500 | 2,337,500 | 7,998,200 | 7,998,200 | 7,998,200 |
| End Cash Position | 2,365,100 | 1,699,000 | 2,337,500 | 1,563,800 | 2,290,200 |
| Net Cash Flow | $27,600 | $-638,500 | $-5,660,700 | $-6,434,400 | $-5,708,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,877,800 | 382,400 | 4,836,600 | 2,872,900 | 1,362,800 |
| Capital Expenditure | -540,100 | -258,300 | -1,033,900 | -707,400 | -444,000 |
| Free Cash Flow | 2,337,700 | 124,100 | 3,802,700 | 2,165,500 | 918,800 |